Elon Musk's company drills through human skulls to install brain chips. China's BrainCo makes wearable headsets. One approach requires a neurosurgeon. The other requires an Amazon account and two AA batteries.
Retail traders now face a choice. Invest in the company that performs irreversible cranial surgery or the one selling what amounts to a Fitbit for your forehead. This is somehow a real investment thesis people are constructing with actual money.
BrainCo believes the future of brain-computer interfaces does not require holes. Neuralink believes it does. Both companies promise to help people with compromised neural abilities. One delivers on that promise without a drill bit. The other comes with an operating room and a liability waiver the size of a phone book.
The BrainCo pitch writes itself. "Our technology does everything theirs does except the part where we open your head." Neuralink's pitch is harder. "Yes we need to cut into your skull but think of the upside." What upside justifies elective brain surgery remains unclear.
Some guy named Kevin just put five thousand dollars into a Neuralink-adjacent ETF because he saw a tweet about cyborgs. Kevin does not know what a blood-brain barrier is. Kevin does not know which company is publicly traded. Kevin knows Elon posted a video of a monkey playing Pong with its mind and that was enough.
BrainCo's approach is boring. Wearables do not generate headlines. Nobody writes articles about a headband. But nobody dies from a headband either. Nobody gets an infection from a headband. Nobody needs general anesthesia for a headband.
The stock market will reward whichever company convinces investors that brain-computer interfaces represent the future. One company requires you to trust a surgeon. The other requires you to trust a strap. Kevin already bought calls on the one with the drill.
Photo by on Unsplash
Leave a Comment